| Literature DB >> 29263232 |
Katie J Ryan1,2,3,4, Charles C White1,2,4, Kruti Patel1,2,3,4, Jishu Xu1,2,4, Marta Olah4,5, Joseph M Replogle1,2,3,4, Michael Frangieh1,2,4, Maria Cimpean1,2,4, Phoebe Winn1,2,4, Allison McHenry1,2,4, Belinda J Kaskow1,2,3,4, Gail Chan1,2,3,4, Nicole Cuerdon1,2,3,4, David A Bennett6, Justin D Boyd1,3, Jaime Imitola7, Wassim Elyaman4,5, Philip L De Jager4,5, Elizabeth M Bradshaw8,5.
Abstract
Microglia are emerging as a key cell type in neurodegenerative diseases, yet human microglia are challenging to study in vitro. We developed an in vitro cell model system composed of human monocyte-derived microglia-like (MDMi) cells that recapitulated key aspects of microglia phenotype and function. We then used this model system to perform an expression quantitative trait locus (eQTL) study examining 94 genes from loci associated with Alzheimer's disease, Parkinson's disease, and multiple sclerosis. We found six loci (CD33, PILRB, NUP160, LRRK2, RGS1, and METTL21B) in which the risk haplotype drives the association with both disease susceptibility and altered expression of a nearby gene (cis-eQTL). In the PILRB and LRRK2 loci, the cis-eQTL was found in the MDMi cells but not in human peripheral blood monocytes, suggesting that differentiation of monocytes into microglia-like cells led to the acquisition of a cellular state that could reveal the functional consequences of certain genetic variants. We further validated the effect of risk haplotypes at the protein level for PILRB and CD33, and we confirmed that the CD33 risk haplotype altered phagocytosis by the MDMi cells. We propose that increased LRRK2 gene expression by MDMi cells could be a functional outcome of rs76904798, a single-nucleotide polymorphism in the LRKK2 locus that is associated with Parkinson's disease.Entities:
Mesh：
Substances：
Year: 2017 PMID： 29263232 PMCID： PMC5945290 DOI： 10.1126/scitranslmed.aai7635
Source DB: PubMed Journal: Sci Transl Med ISSN： 1946-6234 Impact factor: 17.956